AOD-9604 (a modified hGH fragment) is supplied by Onyx Peptides as a high-purity research material for laboratory use, with tracked, discreet UK dispatch.
What is AOD-9604?
AOD-9604 is a modified form of the growth hormone fragment 177-191, with an extra amino acid (tyrosine) added.
How AOD-9604 is studied
It was developed in Australia as a candidate for obesity research, and was studied in clinical trials that did not lead to an approved medicine. It remains a research tool for fat-metabolism studies.
- Lipid metabolism models
- Comparisons with HGH Fragment 176-191
AOD-9604 from Onyx Peptides
We supply AOD-9604 in 5 mg vials. Every batch is independently tested by HPLC to ≥99% purity before it is listed, and carries a batch number that links to its certificate of analysis.
Storage and delivery
Supplied as a lyophilised (freeze-dried) powder in a sealed glass vial. Store the sealed vial frozen (below −18 °C) and away from light.
Orders are dispatched from the UK by tracked delivery in plain, discreet black padded packaging, with no product names on the outside. See shipping & delivery.
Frequently asked questions
What is AOD-9604?
AOD-9604 is a modified form of the growth hormone fragment 177-191, with an extra amino acid (tyrosine) added..
Is AOD-9604 a licensed medicine in the UK?
AOD-9604 is not a licensed medicine in the UK. Onyx Peptides supplies it only as a research material for in-vitro laboratory use.
How is AOD-9604 supplied?
Supplied as a lyophilised (freeze-dried) powder in a sealed glass vial. Store the sealed vial frozen (below −18 °C) and away from light. Each batch is HPLC-tested to at least 99% purity.
How is my order packaged?
In plain, discreet black padded packaging with no product names on the outside, sent by tracked UK delivery.
